85 related articles for article (PubMed ID: 26744502)
1. Transient human anti-mouse antibody generated with immune enhancement in a carbohydrate antigen 19-9 immunoassay after surgical resection of recurrent cancer.
Nakano K; Yasuda K; Shibuya H; Moriyama T; Kahata K; Shimizu C
Ann Clin Biochem; 2016 Jul; 53(Pt 4):511-5. PubMed ID: 26744502
[TBL] [Abstract][Full Text] [Related]
2. False elevation of serum CA-125 level caused by human anti-mouse antibodies.
Bertholf RL; Johannsen L; Guy B
Ann Clin Lab Sci; 2002; 32(4):414-8. PubMed ID: 12458896
[TBL] [Abstract][Full Text] [Related]
3. Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access GI Monitor assay on the UniCel Dxl 800 Immunoassay System.
Stieber P; Molina R; Gion M; Gressner A; Troalen F; Holdenrieder S; Auge JM; Zancan M; Wycislo M; Jarrige V
Clin Chem Lab Med; 2008; 46(5):600-11. PubMed ID: 18598202
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9).
Berth M; Bosmans E; Everaert J; Dierick J; Schiettecatte J; Anckaert E; Delanghe J
Clin Chem Lab Med; 2006; 44(9):1137-9. PubMed ID: 16958610
[TBL] [Abstract][Full Text] [Related]
5. [Examination of the patient serum presenting a CEA false high value after cancer immuno-cell therapy].
Abe M; Matsuura T; Hyoki M; Abe I; Tanigawa K; Kaito K
Rinsho Byori; 2011 Aug; 59(8):763-9. PubMed ID: 21942086
[TBL] [Abstract][Full Text] [Related]
6. False positive carbohydrate antigen 19-9 (CA19-9) results due to a low-molecular weight interference in an apparently healthy male.
Monaghan PJ; Leonard MB; Neithercut WD; Raraty MG; Sodi R
Clin Chim Acta; 2009 Aug; 406(1-2):41-4. PubMed ID: 19463797
[TBL] [Abstract][Full Text] [Related]
7. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
[TBL] [Abstract][Full Text] [Related]
8. An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays.
Covinsky M; Laterza O; Pfeifer JD; Farkas-Szallasi T; Scott MG
Clin Chem; 2000 Aug; 46(8 Pt 1):1157-61. PubMed ID: 10926897
[TBL] [Abstract][Full Text] [Related]
9. [Extraordinary high elevation of serum CA19-9 levels in an apparently healthy subject].
Kaneko Y; Shibata Y; Nakamura H; Kuroda M; Nakazima T; Kasakura S
Rinsho Byori; 1999 Oct; 47(10):943-8. PubMed ID: 10590668
[TBL] [Abstract][Full Text] [Related]
10. [False positive of DUPAN-2 caused by IgM-human anti mouse antibody].
Abe M; Hyoki M; Abe I; Kaito K; Takagi I
Rinsho Byori; 2012 Nov; 60(11):1065-9. PubMed ID: 23383575
[TBL] [Abstract][Full Text] [Related]
11. Markedly increased vitamin B12 concentrations attributable to IgG-IgM-vitamin B12 immune complexes.
Bowen RA; Drake SK; Vanjani R; Huey ED; Grafman J; Horne MK
Clin Chem; 2006 Nov; 52(11):2107-14. PubMed ID: 17068171
[TBL] [Abstract][Full Text] [Related]
12. [IgG heterophile antibody causes false positivity for CA19-9, which is overcome with bovine immunoglobulin].
Miura H; Kitano M; Yoneyama A; Kuwahara A; Moriyama K; Kitajima S
Rinsho Byori; 2005 Dec; 53(12):1103-8. PubMed ID: 16447681
[TBL] [Abstract][Full Text] [Related]
13. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
Carpelan-Holmström MA; Haglund CH; Järvinen HJ; Roberts PJ
Anticancer Res; 1996; 16(2):981-6. PubMed ID: 8687164
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of IgG and IgM human anti-mouse antibodies (HAMA) interference in CA 125 measurements using affinity chromatography.
Koper NP; Thomas CM; Massuger LF; Segers MF; Olthaar AJ; Verbeek AL
Clin Chem Lab Med; 1998 Jan; 36(1):23-8. PubMed ID: 9594082
[TBL] [Abstract][Full Text] [Related]
15. False increase in serum C-reactive protein caused by monoclonal IgM-lambda: a case report.
Yu A; Pira U
Clin Chem Lab Med; 2001 Oct; 39(10):983-7. PubMed ID: 11758616
[TBL] [Abstract][Full Text] [Related]
16. [Survival of patients with liver metastasis from colorectal cancer by different modes of therapy: a report of 363 cases].
Xu JM; Qin XY; Zhong YS; Wei Y; Fan J; Zhou J; Qin LX; Wang JH; Yan ZP; Cheng JM; Wu ZH
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):54-7. PubMed ID: 17575696
[TBL] [Abstract][Full Text] [Related]
17. [Nonspecific reacting materials that interferes tacrolimus assay by ACMIA].
Abei M; Yagi M; Watanabe T; Sugimoto K; Tanno Y; Kaito K
Rinsho Byori; 2013 Nov; 61(11):983-8. PubMed ID: 24450102
[TBL] [Abstract][Full Text] [Related]
18. An illustration of the clinical relevance of detecting human antimouse antibody interference by affinity chromatography.
Koper NP; Massuger LF; Thomas CM; Beyer C; Crooy MJ
Eur J Obstet Gynecol Reprod Biol; 1999 Oct; 86(2):203-5. PubMed ID: 10509792
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal anti-idiotypic antibody against a human monoclonal IgM with specificity for myelin-associated glycoprotein.
Page N; Murray N; Perruisseau G; Steck AJ
J Immunol; 1985 May; 134(5):3094-9. PubMed ID: 2580012
[TBL] [Abstract][Full Text] [Related]
20. Human immune response to group A streptococcal carbohydrate (A-CHO). II. Antigen-independent stimulation of IgM anti-A-CHO production in purified B cells by a monoclonal anti-idiotopic antibody.
Bloem A; Zenke G; Eichmann K; Emmrich F
J Immunol; 1988 Jan; 140(1):277-82. PubMed ID: 2447171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
